| 2025-02-02 15-11-11 | Taking Medium Chain Triglycerides (MCTs) during Insulin-induced Hypoglycemia does not impact the clinical symptoms of hypoglycemia |
| 2025-02-02 15-20-05 | Cognitive Performance during Hypoglycemia is not reduced in people with Type 1 Diabetes when they take Medium Chain Triglycerides (MCTs) during hypoglycemia due to an increase in plasma Beta-Hydroxybutyrate (BHB) |
| 2025-02-02 15-08-43 | Taking Medium Chain Triglycerides (MCTs) during Insulin-induced Hypoglycemia does not prevent an increase in plasma Norepinephrine levels |
| 2025-02-02 15-07-50 | Taking Medium Chain Triglycerides (MCTs) during Insulin-induced Hypoglycemia does not prevent an increase in plasma Epinephrine levels |
| 2025-02-02 14-55-33 | Cognitive Performance is not reduced during Insulin-induced Hypocalcemia in people with Type 1 Diabetes when they take Medium Chain Triglycerides (MCTs) during hypoglycemia |
| 2025-02-02 14-53-51 | Medium Chain Triglycerides (MCTs) increase plasma levels of Beta-Hydroxybutyrate (BHB) in people with Type 1 Diabetes even when plasma Insulin levels are increased |
| 2025-02-02 14-52-58 | Medium Chain Triglycerides (MCTs) increase plasma Free Fatty Acids (FFA) in people with Type 1 Diabetes even in the presence of increased plasma Insulin |
| 2025-01-17 14-20-15 | Emulsifying Medium Chain Triglycerides (MCTs) increases Ketogenesis from MCTs |
| 2025-01-22 17-22-21 | Breath Acetone increases for increasing Medium Chain Triglycerides (MCTs) doses up to 100 grams |
| 2025-01-22 17-12-41 | Increasing the dose of Medium Chain Triglycerides (MCTs) up to 42g can increase Ketogenesis when taken with Carbohydrates |
| 2025-01-17 14-20-29 | Emulsifying Medium Chain Triglycerides (MCTs) reduces stomach upset from MCTs |